McMaster University

McMaster University

Geriatrics Header

7th Annual Update in Geriatrics
Drugs and the Elderly: Balancing Risks and Benefits

Wednesday, November 29, 2017

Liuna Station,
360 James Street North,
Hamilton, ON


Register Brochure Email Updates

 

FOR ACTIVITY INFORMATION

NATALIE PARK
CHSE Coordinator
McMaster University, Continuing Health Sciences Education Program

P: 905-525-9140 x 20763
E: parkna@mcmaster.ca

 

REGISTRATION FEES

Physicians & Other Health Professionals
Before November 1: $175
After November 1: $200

Residents/Students
Before November 1: $75
After November 1: $100

 

TARGET AUDIENCE

Family Physicians, General Internal Medicine Physicians, Physician Assistants, Nurses, Nurse Practitioners, Occupational Therapists, Physiotherapists, Social Workers, Pharmacists, Other Health Care Professionals, Students, and Residents.

 

LEARNING OBJECTIVES
    By attending this activity, participants will be able to:
  • Acquire evidence-based and practical approaches to Drugs and the Elderly.
  • Address key topics such as Deprescibing Benzo’s, Addictions and Narcotics, Cannabis, Diabetes, Vaccines, in addition to other important topics relating to medications and older adults.

 

FEATURED SPEAKERS

Dr. Cara Tannenbaum
Cara Tannenbaum, Professor of Medicine and Pharmacy, is the Director of the Canadian Deprescribing Network. She holds the Michel Saucier Endowed Chair in Geriatric Pharmacology, Health and Aging in the Faculty of Pharmacy at the Université de Montréal since 2008. She completed her internal medicine, geriatric specialty training and research thesis in Epidemiology and Biostatistics at McGill University. Dr. Tannenbaum conducted the EMPOWER trial, and is currently leading the DEPRESCRIBE trial, another Canadian trial to reduce inappropriate prescriptions in seniors. In 2013 she received the Canadian Institutes of Health Prize for Knowledge Translation in Aging. She continues to work as a geriatrician and older women’s health specialist at the Institut universitaire de geriatrie de Montreal in Quebec.


Dr. Karin Neufeld
Dr. Karin Neufeld is a graduate of the University of Manitoba, School of Medicine in Canada. After completing a residency and fellowship in the Department of Psychiatry & Behavioral Sciences at the Johns Hopkins University School of Medicine and a Masters of Public Health degree at the Johns Hopkins Bloomberg School of Public Health, she joined the medical school faculty where she is currently an Associate Professor. Dr. Neufeld has held a number of clinical and leadership positions in the department and is currently the Clinical Director of the Department of Psychiatry at the Johns Hopkins Bayview Medical Center and the Director of the General Hospital Inpatient Psychiatry Consultation Service. Her primary area of academic and clinical interest is in improving delirium prevention and treatment strategies within the acute inpatient setting, with particular focus on the critically ill and older aged postoperative populations. She is the Chair of the Johns Hopkins Delirium Consortium, and Past President and ongoing Board Member of the American Delirium Society. Dr. Neufeld is a member of the Society for Critical Care Medicine and is serving as a delirium expert on the SCCM’s guideline review group for the 2018 edition of the Pain, Agitation, and Delirium (PAD) Guidelines.

Valid XHTML 1.0 Transitional Level Double-A conformance, W3C WAI Web Content Accessibility Guidelines 2.0